Clinical Trial Update: Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating a luteinizing hormone-releasing hormone analogue in combination with enzalutamide, with or without zol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)
• Luteinizing hormone-releasing hormone analogue
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Conditions: Prostate Cancer, Bone Metastases | Phase 2 | Status: COMPLETED